Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@jax.org
Ref Type | |||||||||||||
PMID | |||||||||||||
Authors | J\E. Lancet, GL. Uy, JE. Cortes, LF. Newell, TL. Lin, EK. Ritchie, RK. Stuart, SA Strickland, D Hogge, SR. Solomon, RM. Stone, DL. Bixby, JE. Kolitz, GJ. Schiller, MJ Wieduwilt, DH. Ryan, A Hoering, M Chiarella, AC Louie, BC. Medeiros | ||||||||||||
Title | Final results of a phase III randomized trial of CPX-351 versus 7+3 in older patients with newly diagnosed high risk (secondary) AML. | ||||||||||||
|
|||||||||||||
URL | http://ascopubs.org/doi/abs/10.1200/JCO.2016.34.15_suppl.7000 | ||||||||||||
Abstract Text | Journal of Clinical Oncology 34, no. 15_suppl (May 20 2016) 7000-7000 |
Molecular Profile | Treatment Approach |
---|
Gene Name | Source | Synonyms | Protein Domains | Gene Description | Gene Role |
---|
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|
Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
---|
Gene | Variant | Impact | Protein Effect | Variant Description | Associated with drug Resistance |
---|
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|